{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:06:55Z","timestamp":1771657615347,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-43","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:02:08Z","timestamp":1394150528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The \u201chidden\u201d epidemic: a snapshot of Moroccan intravenous drug users"],"prefix":"10.1186","volume":"11","author":[{"given":"Roxana-Delia","family":"Trimbitas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Zahra","family":"Serghini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatiha","family":"Lazaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warda","family":"Baha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrahim","family":"Foullous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Essalhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelouahed","family":"El Malki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkrim","family":"Meziane Bellefquih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelouaheb","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"issue":"6","key":"2549_CR1","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/hep.22534","volume":"48","author":"CK Aitken","year":"2008","unstructured":"Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M: High incidence of Hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008,48(6):1746-1752. 10.1002\/hep.22534","journal-title":"Hepatology"},{"issue":"5424","key":"2549_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1126\/science.285.5424.26","volume":"285","author":"J Cohen","year":"1999","unstructured":"Cohen J: The scientific challenge of Hepatitis C. Science 1999,285(5424):26-30. 10.1126\/science.285.5424.26","journal-title":"Science"},{"key":"2549_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","volume":"12","author":"J Grebley","year":"2012","unstructured":"Grebley J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ: Hepatitis C viral clearance, reinfection, and persistence, with insights from studies of injection drug users: towards a vaccine. The Lancet 2012, 12: 408-414.","journal-title":"The Lancet"},{"issue":"7447","key":"2549_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/497018a","volume":"497","author":"B Mole","year":"2013","unstructured":"Mole B: Targeted drugs to tackle hepatitis C. Nature 2013,497(7447):18-19. 10.1038\/497018a","journal-title":"Nature"},{"key":"2549_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.3183","volume":"19","author":"TJ Liang","year":"2013","unstructured":"Liang TJ: Current progress in development of Hepatitis C vaccines. Nat Med 2013, 19: 869-878. 10.1038\/nm.3183","journal-title":"Nat Med"},{"key":"2549_CR6","first-page":"719494","volume":"2012","author":"M Daw","year":"2012","unstructured":"Daw M, Dau A: Hepatitis C virus in the Arab world: a state of concern. The Scientific World Journal 2012, 2012: 719494.","journal-title":"The Scientific World Journal"},{"key":"2549_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2334-13-288","volume":"133","author":"Y Mohamoud","year":"2013","unstructured":"Mohamoud Y, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ: The Epidemiology of Hepatitis C virus in Egypt: a systemic review and data synthesis. BMC Infect Dis 2013, 133: 288.","journal-title":"BMC Infect Dis"},{"issue":"33","key":"2549_CR8","doi-asserted-by":"publisher","first-page":"14757","DOI":"10.1073\/pnas.1008877107","volume":"107","author":"FD Miller","year":"2010","unstructured":"Miller FD, Laith AR: Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010,107(33):14757-14762. 10.1073\/pnas.1008877107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2549_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2458-13-50","volume":"13","author":"W Baha","year":"2013","unstructured":"Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, Oukkache B, Lazar F, Benjelloun S, Ennaji MM, Elmalki A, Mifdal H, Bennani A: Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health 2013, 13: 50. 10.1186\/1471-2458-13-50","journal-title":"BMC Public Health"},{"key":"2549_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.patbio.2008.07.006","volume":"57","author":"A Benouda","year":"2009","unstructured":"Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M: Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. Pathologie Biologie 2009, 57: 368-372. 10.1016\/j.patbio.2008.07.006","journal-title":"Pathologie Biologie"},{"issue":"2","key":"2549_CR11","first-page":"169","volume":"24","author":"P Cacoub","year":"2000","unstructured":"Cacoub P, Ohayon V, Sekkat S, Dumont B, Sbai A, Lunel F, Benslimane A, Godeau P, Archane MI: Epidemiologic and virologic study of hepatitis C virus infections in Morocco. Gastroenterologie Clinique et Biologie 2000,24(2):169-173.","journal-title":"Gastroenterologie Clinique et Biologie"},{"issue":"40 Suppl 5","key":"2549_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1086\/427475","volume":"15","author":"M Backmund","year":"2005","unstructured":"Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R: Hepatitis C virus infection and injection in intravenous drug user: prevention, risk factors, and treatment. Clin Infect Dis 2005,15(40 Suppl 5):330-335.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2549_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/432618","volume":"41","author":"M Miller","year":"2005","unstructured":"Miller M, Haley C, Koziel MJ, Rowley CF: Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005,41(5):713-720.","journal-title":"Clin Infect Dis"},{"key":"2549_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-011-0236-z","volume":"40","author":"S Ramia","year":"2012","unstructured":"Ramia S, Melhem M, Kreidieh K: Hepatitis C virus infection in the Middle East and North Africa \u201cMENA\u201d region: injecting drug users (IDUs) is an under-investigated population. Infection 2012, 40: 1-10.","journal-title":"Infection"},{"key":"2549_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1743-422X-7-96","volume":"7","author":"Z Mahfoud","year":"2010","unstructured":"Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S: Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virol J 2010, 7: 96. 10.1186\/1743-422X-7-96","journal-title":"Virol J"},{"issue":"1","key":"2549_CR16","first-page":"26","volume":"15","author":"M Raptopoulou","year":"2011","unstructured":"Raptopoulou M, Touloumi G, Tzourmakliotis D, Nikolopoulou G, Dimopoulou M, Giannoulis G, Vasiliadis T, Skoutelis A, Anagnostou O, Hatzis G, Manolakopoulos S: Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia 2011,15(1):26-31.","journal-title":"Hippokratia"},{"issue":"3","key":"2549_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF02771846","volume":"26","author":"A Vince","year":"1998","unstructured":"Vince A, Palmovi\u0107 D, Kutela N, Sonicky Z, Jeren T, Radovani M: HCV Genotypes in patients with chronic hepatitis C in Croatia. Infection 1998,26(3):173-177. 10.1007\/BF02771846","journal-title":"Infection"},{"key":"2549_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1023\/A:1011060505152","volume":"16","author":"G Stamenkovic","year":"2001","unstructured":"Stamenkovic G, Zerjav S, Velickovic ZM, Krtolica K, Samardzija VL, Jemuovic L, Nozic D, Dimitrijevic B: Distribution of HCV genotypes among risk groups in Serbia. Eur J Epidemiol 2001, 16: 949-954.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2549_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1023\/A:1007324300358","volume":"13","author":"S Cicciarello","year":"1997","unstructured":"Cicciarello S, Borgia G, Crowell J, Ciampi R, Cerini R, Orlando R, Mainolfi M, Reynaud L, Milano M, Piazza M: Prevalence of hepatitis C virus genotypes in southern Italy. Eur J Epidemiol 1997,13(1):49-54. 10.1023\/A:1007324300358","journal-title":"Eur J Epidemiol"},{"key":"2549_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1386-6346(97)00084-3","volume":"9","author":"T Stroffolini","year":"1997","unstructured":"Stroffolini T, Fiumeb A, Fataleb G, Regnib F, Ciccozzia M, Marzolinia A, Mele A: Hepatitis C virus among intravenous drug users in Italy. Hepatology Research 1997, 9: 20-27. 10.1016\/S1386-6346(97)00084-3","journal-title":"Hepatology Research"},{"key":"2549_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2893.2005.00605.x","volume":"12","author":"C Payan","year":"2005","unstructured":"Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coud\u00e9 M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourli\u00e8re M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, et al.: Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 2005, 12: 405-413. 10.1111\/j.1365-2893.2005.00605.x","journal-title":"J Viral Hepat"},{"issue":"36","key":"2549_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1469-0691.1997.tb00472.x","volume":"3","author":"AP Alonso Alonso","year":"1997","unstructured":"Alonso Alonso AP, Ordu\u00f1a A, San Miguel A, Dominguez E, Bratos MA, Gutierrez MP, Eiros JM, Inglada L, Gonzalez Hernandez JM, Rodriguez Torres A: Relation of hepatitis C virus genotypes to risk factors and hepatic disease in Spanish patients. Clin Microbiol Infect 1997,3(36):647-652.","journal-title":"Clin Microbiol Infect"},{"key":"2549_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/jmv.21955","volume":"83","author":"R Almeida Calado","year":"2011","unstructured":"Almeida Calado R, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A: Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. J Med Virol 2011, 83: 608-615. 10.1002\/jmv.21955","journal-title":"J Med Virol"},{"key":"2549_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nephro.2007.11.007","volume":"4","author":"S Sekkat","year":"2008","unstructured":"Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, El Kholti A, Benslimane A: Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Nephrol Ther 2008, 4: 105-110.","journal-title":"Nephrol Ther"},{"issue":"4","key":"2549_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/(SICI)1096-9071(199708)52:4<396::AID-JMV9>3.0.CO;2-X","volume":"52","author":"A Benani","year":"1997","unstructured":"Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A: HCV genotypes in Morocco. J Med Virol 1997,52(4):396-398. 10.1002\/(SICI)1096-9071(199708)52:4<396::AID-JMV9>3.0.CO;2-X","journal-title":"J Med Virol"},{"issue":"4","key":"2549_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0923-2516(96)89656-7","volume":"147","author":"S Benjelloun","year":"1996","unstructured":"Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A: Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Res Virol 1996,147(4):247-255. 10.1016\/0923-2516(96)89656-7","journal-title":"Res Virol"},{"issue":"1","key":"2549_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/ADM.0b013e318279756f","volume":"7","author":"E Gigi","year":"2013","unstructured":"Gigi E, Sinakos E, Sykja A, Androulakis G, Tanis C, Stayridou V, Tsirogianni E, Zouridakis K, Bellou AL, Orfanou E, Raptopoulou-Gigi M: Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users. Addict Med 2013,7(1):52-57. 10.1097\/ADM.0b013e318279756f","journal-title":"Addict Med"},{"issue":"1","key":"2549_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.25652","volume":"56","author":"L Uccellini","year":"2012","unstructured":"Uccellini L, Tseng FC, Monaco A, Shebl FM, Pfeiffer R, Dotrang M, Buckett D, Busch MP, Wang E, Edlin BR, Marincola FM, O'Brien TR: HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 2012,56(1):86-94. 10.1002\/hep.25652","journal-title":"Hepatology"},{"key":"2549_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1258\/ijsa.2008.008362","volume":"20","author":"YP Bao","year":"2009","unstructured":"Bao YP, Liu ZM: Systematic review of HIV and HCV infection among drug users in China. International Journal of STDs & AIDS 2009, 20: 399-405. 10.1258\/ijsa.2008.008362","journal-title":"International Journal of STDs & AIDS"},{"key":"2549_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1086\/322795","volume":"184","author":"C Mathei","year":"2001","unstructured":"Mathei C, Butinax F, Van Damme P: Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age? J Infect Dis 2001, 184: 659-660. 10.1086\/322795","journal-title":"J Infect Dis"},{"issue":"4","key":"2549_CR31","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/hep.25770","volume":"56","author":"J Rice","year":"2012","unstructured":"Rice J, Burnett D, Tsotsis H, Lindstrom MJ, Cornett DD, Voermans P, Sawyer J, Striker R, Lucey MR: Comparison of hepatitis C virus treatment between incarcerated and community patients. Hepatology 2012,56(4):1252-1260. 10.1002\/hep.25770","journal-title":"Hepatology"},{"key":"2549_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/infdis\/jis677","volume":"207","author":"J Doerrbecker","year":"2013","unstructured":"Doerrbecker J, Behrendt P, Mateu-Gelabert P, Ciesek S, Riebesehl N, Wilhelm C, Steinmann J, Pietschmann T, Steinmann E: Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J Infect Dis 2013, 207: 81-87.","journal-title":"J Infect Dis"},{"key":"2549_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/1743-422X-8-466","volume":"8","author":"A Amjad","year":"2011","unstructured":"Amjad A, Nisar M, Ahmad H, Saif N, Idrees M, Bajwa MA: Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virol J 2011, 8: 466. 10.1186\/1743-422X-8-466","journal-title":"Virol J"},{"issue":"2","key":"2549_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1020161818764","volume":"25","author":"E Yildiz","year":"2002","unstructured":"Yildiz E, Oztan A, Sar F, Pinarbasi E, Cetin-Atalay R, Akkiz H, Ozturk M: Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey. Virus Genes 2002,25(2):169-177. 10.1023\/A:1020161818764","journal-title":"Virus Genes"},{"key":"2549_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0168-8278(97)80137-7","volume":"27","author":"F Lopez-Labrador","year":"1997","unstructured":"Lopez-Labrador F, Ampurdan\u00e9s S, Forns X, Castells A, S\u00e1iz JC, Costa J, Bruix J, S\u00e1nchez Tapias JM, de Anta MT J, Rod\u00e9s J: Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997, 27: 959-965. 10.1016\/S0168-8278(97)80137-7","journal-title":"J Hepatol"},{"issue":"40","key":"2549_CR36","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.3748\/wjg.15.5114","volume":"15","author":"S Rouabhia","year":"2009","unstructured":"Rouabhia S, Malek R, Bounecer H: Association of hepatitis C virus infection and diabetes. World J Gastroenterol 2009,15(40):5114-5115. 10.3748\/wjg.15.5114","journal-title":"World J Gastroenterol"},{"key":"2549_CR37","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1099\/0022-1317-75-9-2393","volume":"75","author":"LZ Xu","year":"1994","unstructured":"Xu LZ, Larzul D, Delaporte E, Brechot C, Kremsdorf D: Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol 1994, 75: 2393-239. 10.1099\/0022-1317-75-9-2393","journal-title":"J Gen Virol"},{"key":"2549_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D: Evolvingepidemiology of hepatitis C virus. Clin Microbiol Infect 2011, 17: 107-115. 10.1111\/j.1469-0691.2010.03432.x","journal-title":"Clin Microbiol Infect"},{"issue":"380","key":"2549_CR39","first-page":"15","volume":"95","author":"F Garcia","year":"1998","unstructured":"Garcia F, Rold\u00e1n C, Garc\u00eda F Jr, Hern\u00e1ndez J, Garc\u00eda-Valdecasas J, Bernal MC, Pi\u00e9drola G, Maroto MC: Subtype distribution among intravenous drug users with chronic type C hepatitis in southern Spain. Microbios 1998,95(380):15-24.","journal-title":"Microbios"},{"issue":"2","key":"2549_CR40","first-page":"433","volume":"11","author":"A Schijman","year":"2004","unstructured":"Schijman A, Colina R, Mukomolov S, Kalinina O, Garc\u00eda L, Broor S, Bhupatiraju AV, Karayiannis P, Khan B, Mogdasy C, Cristina J: Comparison of Hepatitis C virus viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol 2004,11(2):433-435.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"2549_CR41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1128\/CDLI.8.4.690-694.2001","volume":"8","author":"J Matthews-Greer","year":"2001","unstructured":"Matthews-Greer J, Caldito G, Adley S, Willis R, Mire A, Jamison R, McRae K, King J, Chang WL: Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Vaccine Immunol 2001,8(4):690-694. 10.1128\/CDLI.8.4.690-694.2001","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"2549_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/00002030-199510000-00003","volume":"9","author":"B Cribier","year":"1995","unstructured":"Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 1995,9(10):1131-1136. 10.1097\/00002030-199510000-00003","journal-title":"AIDS"},{"issue":"Suppl 1","key":"2549_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/liv.12082","volume":"33","author":"M Sulkowsky","year":"2013","unstructured":"Sulkowsky M: HCV therapy in HIV-infected patients. Liver Int 2013,33(Suppl 1):63-70.","journal-title":"Liver Int"},{"key":"2549_CR44","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jmv.20992","volume":"79","author":"P Filippini","year":"2007","unstructured":"Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, Sagnelli C, Filippini A, Sagnelli E: Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. J Med Virol 2007, 79: 1679-1685. 10.1002\/jmv.20992","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"2549_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/liv.12053","volume":"33","author":"S Petta","year":"2013","unstructured":"Petta S, Craxi A: How to optimize HCV therapy in genotype 1 patients: predictors of response. Liver Int 2013,33(Suppl 1):23-29.","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"2549_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/liv.12056","volume":"33","author":"E Grassi","year":"2013","unstructured":"Grassi E, Aghemo A: How to optimize HCV therapy in genotype 2 patients. Liver Int 2013,33(Suppl 1):35-40.","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"2549_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1478-3231.2011.02704.x","volume":"32","author":"G Esmat","year":"2012","unstructured":"Esmat G, El Raziky M, El Kassas M, Hassany M, Gamil ME: The future for the treatment of genotype 4 chronic hepatitis C. Liver Int 2012,32(Suppl 1):146-50.","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"2549_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/liv.12080","volume":"33","author":"A Chopra","year":"2013","unstructured":"Chopra A, Klein PL, Drinnan T, Lee SS: How to optimize HCV therapy in genotype 1 patients: management of side-effects. Liver Int 2013,33(Suppl. 1):30-40.","journal-title":"Liver Int"},{"key":"2549_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-230X-12-162","volume":"12","author":"A Pellicelli","year":"2012","unstructured":"Pellicelli A, Romano M, Stroffolini T, Mazzoni E, Mecenate F, Monarca R, Picardi A, Bonaventura ME, Mastropietro C, Vignally P, Andreoli A, Marignani M, D'Ambrosio C, Miglioresi L, Nosotti L, Mitidieri O, Gentilucci UV, Puoti C, Barbaro G, Barlattani A, Furlan C, Barbarini G: HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b. BMC Gastroenterol 2012, 12: 162. 10.1186\/1471-230X-12-162","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"2549_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","volume":"13","author":"N Zein","year":"2000","unstructured":"Zein N: Clinical significance of Hepatitis C virus genotypes. Clin Microbiol Rev 2000,13(2):223-235. 10.1128\/CMR.13.2.223-235.2000","journal-title":"Clin Microbiol Rev"},{"issue":"30","key":"2549_CR51","first-page":"154","volume":"7","author":"A Jazwinski","year":"2011","unstructured":"Jazwinski A, Muir A: Direct-Acting Antiviral Medications for Chronic Hepatitis C Virus Infection. Gastroenterology & Hepatology 2011,7(30):154-162.","journal-title":"Gastroenterology & Hepatology"},{"issue":"10","key":"2549_CR52","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.dld.2006.06.006","volume":"38","author":"A Andriulli","year":"2006","unstructured":"Andriulli A, Dalgard O, Bjoro K, Mangia A: Short-term treatment duration for HCV-2 and HCV-3 infected patients. Dig Liver Dis 2006,38(10):741-748. 10.1016\/j.dld.2006.06.006","journal-title":"Dig Liver Dis"},{"key":"2549_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2004.02.007","volume":"40","author":"S Zeuzem","year":"2004","unstructured":"Zeuzem S, Hultcrantz R, Bourliere M, Goeser T, Marcellin P, Sanchez-Tapias J, Sarrazin C, Harvey J, Brass C, Albrecht J: Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol 2004, 40: 993-999. 10.1016\/j.jhep.2004.02.007","journal-title":"J Hepatol"},{"issue":"3","key":"2549_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","volume":"33","author":"S Mehta","year":"2008","unstructured":"Mehta S, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL: Limited Uptake of Hepatitis C Treatment among Injection Drug Users. J Community Health 2008,33(3):126-133. 10.1007\/s10900-007-9083-3","journal-title":"J Community Health"},{"key":"2549_CR55","first-page":"68","volume":"54","author":"LM Hegan","year":"2012","unstructured":"Hegan LM, Schinazi RF: Best strategies for global HCV eradication. Liver Int 2012, 54: 68-79.","journal-title":"Liver Int"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:55:37Z","timestamp":1630583737000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-43","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]},"assertion":[{"value":"20 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43"}}